National Bank of Canada’s Immutep IMMP Stock Holding History

National Bank of Canada’s Portfolio IMMP Stock Details IMMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-300	Closed	-$525	–	2785
2022 Q4	$525	Hold	300	–	–	﹤0.01%	2642
2022 Q3	$0	Hold	300	–	–	﹤0.01%	2780
2022 Q2	$1K	Hold	300	–	–	﹤0.01%	2688
2022 Q1	$1K	Hold	300	–	–	﹤0.01%	2779
2021 Q4	$1K	Buy	+300	New	+$1.15K	﹤0.01%	2745

Other funds holding IMMP

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return

National Bank of Canada's IMMP Position: Q1 2023 in Review

National Bank of Canada sold out of Immutep (IMMP) in Q1 2023, closing a stake of 300 shares — an estimated $525 sold.

National Bank of Canada first reported a position in IMMP in Q4 2021 and held it in 5 quarters. The position peaked at $1K in Q2 2022. 19 funds tracked by Wall St. Rank hold IMMP as of Q1 2023.

National Bank of Canada reported no remaining Immutep position as of Q1 2023 after selling out during the quarter.
National Bank of Canada sold 300 Immutep shares in Q1 2023, an estimated $525.
National Bank of Canada first reported a position in Immutep in Q4 2021 and held it in 5 quarters.
National Bank of Canada's Immutep position peaked at $1K in Q2 2022.
19 funds tracked by Wall St. Rank held Immutep as of Q1 2023.

Based on National Bank of Canada's 13F filing for Q1 2023, filed 12 Apr 2023.